28 Jul 2026 00:10:03 ET │ 10 pages Flash | Cipla (CIPL.BO) gAdvair Approval: Walking the Talk on Complex Generics; Reiterate +ve CW CITI'S TAKE Cipla's USFDA approval for generic Advair is largely in line with expectations and marks the second of four guided respiratory approvals after Ventolin. With Symbicort and Flovent expected over the next few months, Cipla continues to deliver on complex products, supporting a pick-up in US sales and margins. We have anongoing +Ve CW on Cipla. Buy | Catalyst Watch: Up ...